SEC Form 3 · accession 0001596771-17-000002
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin Johnson
Officer — Chief Accounting Officer
Period of report
Jan 3, 2017
Accepted (ET)
Jan 12, 2017 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 41,271 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option to Acquire Common StockF1 | $14.40 | holding | — | — | — | — | Dec 5, 2026 | Common Stock | 75,000 | — | D |
Explanation of responses
- F1The options were granted on December 5, 2016, and will begin to vest in annual increments of 25% of the option grant on the one-year anniversary of the grant date, to be fully vested after four years.
Remarks
Exhibit 24, Power of Attorney, is attached.